{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-016176","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2022-06-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.483779+00:00","generated_at":"2026-06-24T22:19:24.803124+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"DiaMedica Therapeutics subsidiary enters office lease for new headquarters in Minnetonka, MN","bullets":["Lease for approx 6,175 sq ft at 301 Carlson Parkway, Suite 210, Minnetonka, MN.","Initial term 5 years 5 months starting Sept 1, 2022, with option to extend 5 years.","Rent approx $9,000/month after 5-month abatement, plus share of operating expenses and taxes.","Company to relocate principal executive offices and R&D operations from current Plymouth location.","Parent company DiaMedica Therapeutics provides lease guaranty; security deposit $8,750."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-016176","json":"https://secwatch.observer/filing/0001437749-22-016176.json","markdown":"https://secwatch.observer/filing/0001437749-22-016176.md","text":"https://secwatch.observer/filing/0001437749-22-016176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774922016176/0001437749-22-016176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774922016176/dmtp20220623_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T22:19:24.803124+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}